Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 28 for celiac

Edit search filters
  1. A Study To Evaluate The Effectiveness And Safety Of Larazotide Acetate For The Relief Of CeD Symptoms

    Rochester, MN

  2. Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim

    Jacksonville, FL, Rochester, MN

  3. Celiac Disease Tissue Destruction And Healing

    Rochester, MN

  4. Antibody Treatment For Advanced Celiac Disease

    Rochester, MN

  5. Evaluation Of The Efficacy And Safety Of ALV003 In Symptomatic In Celiac Disease Patients

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Study Of Safety, Tolerability, Pharmacodynamics, And Pharmacokinetics Of KAN-101 In People With Celiac Disease

    Rochester, MN

  7. Study Of The Safety, Tolerability, Pharmacokinetics And Biomarker Of DONQ52 In Celiac Disease Patients

    Rochester, MN

  8. Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study In Symptomatic Celiac Disease Patients

    Rochester, MN

  9. A Study To Evaluate The Safety, Effectiveness, And Tolerability Of Latiglutenase To Treat Patients With Well-Controlled Celiac Disease

    Rochester, MN

  10. A Study To Assess The Safety And Tolerability Of Single And Multiple Doses Of KAN-101 In Celiac Disease Patients

    Rochester, MN

.

Mayo Clinic Footer